EU Ruling Turns Days Into €millions For Companies
This article was originally published in Scrip
Just a few days could make a big difference for your company, perhaps millions of Euros. Thanks to a ruling from the Court of Justice of the European Union, some innovative products could have their market exclusivity period extended in some EU markets by a number of days or maybe weeks. This may not seem much on the surface, but it could mean a windfall for the originator company and isn't all bad news for the generics companies, explains Mike Gilbert, a partner at Marks & Clerk Solicitors.
You may also be interested in...
Performance-based managed entry agreements need to be made more effective, but this can only happen if countries relax their stance on confidentiality and share information on MEAs amongst themselves, says a working paper from the OECD.
The Netherlands will secure lower medicine prices by referencing Norway instead of Germany to set maximum prices.
Luxembourg’s new regulator will work to attract investment and improve public health as well as tackle the growing problem of drug shortages.